The FDA’s Vaccines and Related Biological Products Advisory Committee has unanimously recommended replacing the current influenza vaccin...... more

As this is written in late January, the H1N1 pandemic in the United States has subsided to very low levels and there is no sign yet of a wint...... more

Influenza A (H1N1) activity in the United States appears to have declined even further, according to health officials at the CDC who spoke at...... more

Oseltamivir is an orally available neuraminidase inhibitor that has antiviral activity against influenza A and influenza B viruses. It is FDA...... more

Delayed treatment of suspected influenza A (H1N1) illness among pregnant women may result in a four-fold risk of intensive care admission or ...... more

Mortality rates attributable to influenza were 10 times higher in Argentinean children compared to those observed during past seasons and hos...... more

The spread of influenza A (H1N1) in the United States continues to decline, according to new data released this week by the CDC.

The ...... more

Despite current two-dose influenza A (H1N1) vaccine recommendations for children in the United States, Australian infants who received a sing...... more

One dose of the influenza A (H1N1) vaccine was "highly immunogenic" in adults, according to results of a new study published in The Lancet...... more

Officials with Sanofi Pasteur announced today that they are recalling about 800,000 doses of the influenza A (H1N1) vaccine, tha...... more